S. Gray

Darbepoetin alfa administered once monthly maintains haemoglobin levels in stable dialysis patients.

M. Jadoul, R. Walker, Y. Vanrenterghem, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients.

P. Kerr, Y. Vanrenterghem, P. Bárány, 2002, Kidney international.

Correction of anaemia with darbepoetin alfa in patients with chronic kidney disease receiving dialysis.

I. Macdougall, J. Matcham, S. Gray, 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Novel erythropoiesis stimulating protein for treatment of anemia in chronic renal insufficiency.

F. Locatelli, R. Walker, C. Dewey, 2001, Kidney international.

Filgrastim to treat neutropenia and support myelosuppressive medication dosing in HIV infection

W. Rozenbaum, N. Clumeck, F. Castelli, 1996, AIDS.

Pharmacokinetics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patients.

I. Macdougall, J. Egrie, B. Jenkins, 1999, Journal of the American Society of Nephrology : JASN.

Minimum effective dose and duration to reverse neutropenia in non-cancer patients with advanced HIV disease.

N. Clumeck, P. Hermans, S. Gray, 1996, AIDS.